Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AIRSNASDAQ:EUDANASDAQ:OPGNNASDAQ:SERA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIRSAirSculpt Technologies$1.70+6.9%$3.24$1.54▼$9.20$99.58M1.94158,635 shs117,654 shsEUDAEUDA Health$4.04+1.5%$3.84$1.69▼$6.30$99.50M-0.0575,844 shs106,756 shsOPGNOpGen$4.17+1.7%$2.41$0.53▼$6.30$34.85M-1.618,641 shs14,173 shsSERASera Prognostics$3.40+1.5%$3.85$2.99▼$12.36$128.06M0.96130,604 shs86,048 shs7 Top Nuclear Stocks To Buy NowNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIRSAirSculpt Technologies+6.92%-5.56%-34.36%-68.11%-68.58%EUDAEUDA Health+1.51%+10.68%+1.51%+9.78%+139.05%OPGNOpGen+1.71%+4.51%+98.57%+141.04%-30.49%SERASera Prognostics+1.49%+9.32%-16.67%-47.04%-64.88%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAIRSAirSculpt Technologies1.0628 of 5 stars3.00.00.00.00.63.30.0EUDAEUDA Health0.4317 of 5 stars0.03.00.00.01.80.00.6OPGNOpGenN/AN/AN/AN/AN/AN/AN/AN/ASERASera Prognostics0.2976 of 5 stars0.02.00.00.00.82.50.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAIRSAirSculpt Technologies 2.00Hold$3.75120.59% UpsideEUDAEUDA Health 4.00Strong BuyN/AN/AOPGNOpGen 0.00N/AN/AN/ASERASera Prognostics 3.00BuyN/AN/ACurrent Analyst Ratings BreakdownLatest OPGN, SERA, AIRS, and EUDA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/31/2025AIRSAirSculpt TechnologiesLeerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetMarket Perform ➝ Market Perform$6.50 ➝ $2.50(Data available from 4/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAIRSAirSculpt Technologies$180.35M0.55$0.07 per share25.15$1.46 per share1.16EUDAEUDA Health$3.81M26.10N/AN/A($0.30) per share-13.47OPGNOpGen$2.67M13.04N/AN/A($11.55) per share-0.36SERASera Prognostics$77K1,663.09N/AN/A$2.21 per share1.54Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAIRSAirSculpt Technologies-$4.48M-$0.15N/A∞N/A-4.13%2.22%0.90%4/28/2025 (Estimated)EUDAEUDA Health-$10.04MN/A0.00N/AN/AN/AN/AN/A5/6/2025 (Estimated)OPGNOpGen-$32.67MN/A0.00∞N/A-1,140.36%N/A-287.58%6/2/2025 (Estimated)SERASera Prognostics-$36.24M-$0.99N/AN/AN/AN/A-51.73%-36.94%5/14/2025 (Estimated)Latest OPGN, SERA, AIRS, and EUDA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025SERASera Prognostics-$0.24N/AN/AN/AN/AN/A5/9/2025Q1 2025AIRSAirSculpt Technologies-$0.03N/AN/AN/A$40.25 millionN/A5/6/2025N/AEUDAEUDA Health-$0.02N/AN/AN/A$1.34 millionN/A3/19/2025Q4 2024SERASera Prognostics-$0.23-$0.25-$0.02-$0.25$0.01 million$0.02 million3/14/2025Q4 2024AIRSAirSculpt Technologies-$0.03-$0.08-$0.05-$0.09$38.99 million$39.18 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAIRSAirSculpt TechnologiesN/AN/AN/AN/AN/AEUDAEUDA HealthN/AN/AN/AN/AN/AOPGNOpGenN/AN/AN/AN/AN/ASERASera PrognosticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAIRSAirSculpt Technologies0.800.510.51EUDAEUDA HealthN/A0.13N/AOPGNOpGenN/A5.455.45SERASera PrognosticsN/A2.112.11Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAIRSAirSculpt Technologies91.54%EUDAEUDA Health4.35%OPGNOpGen2.68%SERASera Prognostics54.64%Insider OwnershipCompanyInsider OwnershipAIRSAirSculpt Technologies78.77%EUDAEUDA HealthN/AOPGNOpGen43.80%SERASera Prognostics15.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAIRSAirSculpt Technologies24058.58 million12.56 millionOptionableEUDAEUDA Health224.63 millionN/ANot OptionableOPGNOpGen1008.36 million4.70 millionNot OptionableSERASera Prognostics12037.66 million28.44 millionOptionableOPGN, SERA, AIRS, and EUDA HeadlinesRecent News About These CompaniesSera Prognostics: Initiating With Hold, Potential Of PreTRM Test, But Uncertain Commercial TimelineApril 15 at 2:29 AM | seekingalpha.comSera Prognostics Earnings Call: Balancing Success and ChallengesMarch 21, 2025 | tipranks.comSera Prognostics, Inc.: Sera Prognostics Reports Fourth Quarter 2024 Financial ResultsMarch 21, 2025 | finanznachrichten.deEarnings call transcript: Sera Prognostics Q4 2024 sees revenue drop, stock risesMarch 21, 2025 | uk.investing.comTD Cowen Sticks to Its Buy Rating for Sera Prognostics (SERA)March 21, 2025 | markets.businessinsider.comSera Prognostics Full Year 2024 Earnings: Misses ExpectationsMarch 21, 2025 | finance.yahoo.comSera Prognostics (NASDAQ:SERA) Issues Quarterly Earnings ResultsMarch 20, 2025 | marketbeat.comSera Prognostics Plans Studies to Support US and EU Expansion; Firm’s Q4 Revenues Fall 41 PercentMarch 20, 2025 | 360dx.comSera Prognostics Q4 Revenues Fall 41 Percent While Firm Prepares for Commercial ExpansionMarch 20, 2025 | 360dx.comSera Prognostics beats Q4 revenue estimates, shares riseMarch 20, 2025 | investing.comSera Prognostics reports Q4 EPS (25c) vs. (25c) last yearMarch 20, 2025 | markets.businessinsider.comSera Prognostics appoints Jeff Elliott to Board, two members stepping downMarch 20, 2025 | markets.businessinsider.comSera Prognostics Reports 2024 Financial Results and Strategic PlansMarch 19, 2025 | tipranks.comSera Prognostics Inc (SERA) Q4 2024 Earnings Call TranscriptMarch 19, 2025 | seekingalpha.comSera Prognostics, Inc. (SERA) Reports Q4 Loss, Misses Revenue EstimatesMarch 19, 2025 | zacks.comSERA PROGNOSTICS REPORTS FOURTH QUARTER 2024 FINANCIAL RESULTSMarch 19, 2025 | prnewswire.comSERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWNMarch 19, 2025 | prnewswire.comSera Prognostics Announces Conference Call and Webcast of Fourth Quarter and Fiscal Year 2024 Financial Results on March 19, 2025March 11, 2025 | prnewswire.comSera Prognostics To Present at TD Cowen 45th Annual Health Care ConferenceFebruary 21, 2025 | prnewswire.comSera Prognostics chief scientific officer sells shares for $27,090February 16, 2025 | msn.comSera Prognostics CEO sells $64,463 in stockFebruary 14, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesBYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?By Jeffrey Neal Johnson | March 21, 2025View BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?Are Tariffs Threatening Disney’s Comeback Story?By Jea Yu | April 9, 2025View Are Tariffs Threatening Disney’s Comeback Story?3 Defense Stocks Set to Benefit From Increased Military SpendingBy Chris Markoch | March 20, 2025View 3 Defense Stocks Set to Benefit From Increased Military SpendingCan NIO Overcome U.S.-China Tariff Headwinds?By Gabriel Osorio-Mazilli | April 8, 2025View Can NIO Overcome U.S.-China Tariff Headwinds?Airship AI: Why This AI Penny Stock Is Poised for a Big BreakoutBy Nathan Reiff | March 26, 2025View Airship AI: Why This AI Penny Stock Is Poised for a Big BreakoutOPGN, SERA, AIRS, and EUDA Company DescriptionsAirSculpt Technologies NASDAQ:AIRS$1.70 +0.11 (+6.92%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$1.70 0.00 (-0.29%) As of 04/17/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. The company's body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. It operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.EUDA Health NASDAQ:EUDA$4.04 +0.06 (+1.51%) As of 04/17/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company is also involved in the property management that services shopping malls, business office building, or residential apartments. EUDA Health Holdings Limited is headquartered in Singapore.OpGen NASDAQ:OPGN$4.17 +0.07 (+1.71%) As of 04/17/2025 03:10 PM EasternOpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artificial intelligence powered bioinformatics solutions for antibiotic response prediction; and Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers. It also utilizes molecular diagnostics and informatics to help combat infectious diseases. The company helps clinicians with information about life threatening infections to enhance patient outcomes, and to decrease the spread of infections caused by multidrug-resistant microorganisms. OpGen, Inc. has a collaboration with the New York State Department of Health and ILÚM Health Solutions, LLC to develop a research program to detect, track, and manage antimicrobial-resistant infections at healthcare institutions. The company was incorporated in 2001 and is headquartered in Rockville, Maryland.Sera Prognostics NASDAQ:SERA$3.40 +0.05 (+1.49%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$3.40 0.00 (0.00%) As of 04/17/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Archer Aviation Unveils NYC Network Ahead of Key Earnings Report Joby Aviation Stock Presents an Opportunity in the Turbulence Tariff Exemptions Set the Stage for a Taiwan Semiconductor Rally Tariff-Resistant Kinder Morgan Is a Good Buy in 2025 Rocket Lab's Growth Potential Gains Altitude on Defense News Broadcom’s Apple Relationship: AI Opportunity Meets Tariff Risk 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks Tariff-Resistant Abbott Laboratories on Track for New Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
